Markers associated with genomic instability, immunogenicity and immune therapy responsiveness in Metaplastic carcinoma of the breast: Expression of Î³H2AX, pRPA2, P53, PD-L1 and tumor infiltrating lymphocytes in 76 cases.

Voutilainen, S; Heikkilä, P; Bartkova, J; Nevanlinna, H; Blomqvist, C; Bartek, J; Mattson, J

Voutilainen, S; Heikkilä, P; Bartkova, J; Nevanlinna, H; Blomqvist, C; Bartek, J; Mattson, J.

Affiliation

Voutilainen S; Helsinki University Hospital Comprehensive Cancer Centre, Paciuksenkatu 3, PO BOX 180, 00290, Helsinki, Finland. sari.j.voutilainen@hus.fi.
Heikkilä P; Department of Pathology, University of Helsinki and HUSLAB, Helsinki University Hospital, Helsinki, Finland.
Bartkova J; Danish Cancer Society Research Center, Copenhagen, Denmark.
Nevanlinna H; Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Science for Life Laboratory, Karolinska Institute, Stockholm, Sweden.
Blomqvist C; Department of Obstetrics and Gynecology, University of Helsinki, Helsinki University Hospital, Helsinki, Finland.
Bartek J; Helsinki University Hospital Comprehensive Cancer Centre, Paciuksenkatu 3, PO BOX 180, 00290, Helsinki, Finland.
Mattson J; Danish Cancer Society Research Center, Copenhagen, Denmark.

BMC Cancer ; 22(1): 1298, 2022 Dec 12.

Article de En | MEDLINE | ID: mdl-36503417

Sujet(s)
Mots clés

Metaplastic breast cancer; PD-L1; RPA2; TILs; p53; Î³H2AX

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Carcinome épidermoïde / Tumeurs du sein triple-négatives Type d'étude: Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: BMC Cancer Sujet du journal: NEOPLASIAS Année: 2022 Type de document: Article Pays d'affiliation: Finlande Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google